Entries by aaron

Vitamin B3 Supplement Shows Promise in Cutting Skin Cancer Risk: JAMA

USA: A large Veterans Affairs (VA) cohort study has found that taking nicotinamide—a vitamin B3 derivative sold over the counter—significantly lowers the risk of developing skin cancer. The protective effect was strongest when the supplement was started soon after a patient’s first skin cancer diagnosis, according to findings published in JAMA Dermatology by Dr. Kimberly […]

Radioiodine Ablation Therapy Feasible in Hemodialysis-Dependent ESKD Patients with Low-Risk Thyroid Cancer: Case Series

Australia: In a recently published case series in BMC Nephrology, researchers from the University of Sydney, led by Dr. Raymond Lin, have demonstrated that with tailored protocols and safety precautions, radioiodine (I-131) therapy can be safely administered to patients with end-stage kidney disease (ESKD) on haemodialysis (HD) who are being treated for thyroid cancer.     […]

New tracer could enable surgeons to see and hear prostate cancer: Study

A preclinical evaluation of a new ’dual-mode’ tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during surgery. The agent uses a single tracer molecule labeled with Fluorine-18-a common isotope used in Positron Emission Tomography (PET) scans-for diagnostic […]

AI could soon detect early voice box cancer from the sound of your voice, suggests study

Cancer of the voice box or larynx is an important public health burden. In 2021, there were an estimated 1.1 million cases of laryngeal cancer worldwide, and approximately 100,000 people died from it. Risk factors include smoking, alcohol abuse, and infection with human papillomavirus. The prognosis for laryngeal cancer ranges from 35% to 78% survival […]

Cardiovascular Risk Highest in Mothers with Hypertension, Diabetes, or Both: Study

A new study has determined that mothers who experienced pre-pregnancy hypertension, hypertensive disorders of pregnancy (HDP), diabetes, or any combination of these three diseases are at greatly elevated risks of coronary heart disease (CHD) and all-cause mortality in the first five years postpartum. The study was published in BMC Cardiovascular Diabetology journal by Angela M. […]

Midazolam Reduces Breathing Flexibility, While S-Ketamine Preserves It: Pilot Trial Finds

Netherlands: Midazolam sedation can noticeably restrict the natural adaptability of breathing, while s-ketamine largely preserves it, a recent randomized controlled pilot study published in PLOS ONE has shown. Researchers observed that midazolam significantly reduced the variability of both respiratory rate and tidal volume, resulting in a more uniform breathing pattern that may raise the risk […]

Low hemoglobin glycation index Linked to Higher Mortality in Critically Ill Patients: Study

China: Researchers have found in new research that lower hemoglobin glycation index (HGI) values are associated with increased short- and long-term mortality among critically ill patients. Hemoglobin glycation index may be a useful prognostic biomarker for risk stratification in intensive care unit (ICU) settings. The study, led by Benji Wang from the Department of Anesthesiology, […]

Atopic Eczema Significantly Increases Risk of Suicidal Thoughts, Major Study Reveals

A new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic eczema (AE) are significantly more likely to experience suicidal thoughts, with researchers uncovering the key factors driving this elevated risk. As one of the largest global investigations to examine the link between AE […]

Triple Therapy Improves Glucose Control in Cystic Fibrosis: Study

A new study published in the American Journal of Respiratory and Critical Care Medicine found that the combination of elexacaftor, tezacaftor, and ivacaftor significantly improved blood glucose regulation in cystic fibrosis patients with abnormal glucose tolerance. Over 48 weeks, patients showed reductions in 2-hour blood glucose and A1C levels, with no safety concerns. Multiple organs are […]